Widespread screening is needed in critically ill children to detect and mitigate delirium. The
identification of modifiable risk factors has provided an opportunity for delirium prevention …

Over the past few years, despite the lack of approved pediatric labelling, dexmedetomidine's
(DEX) use has become more prevalent in pediatric clinical practice as well as in research …

We aim to develop evidence-based recommendations for intensivists caring for children
admitted to intensive care units and requiring analgesia and sedation. A panel of national …

Background: Acute kidney injury (AKI) is a common postoperative complication in pediatric
patients undergoing cardiac surgery and associated with poor outcomes. Dexmedetomidine …

Background There is a paucity of data on use of dexmedetomidine as a sedative agent in
mechanically ventilated children. Objectives To compare the efficacy of dexmedetomidine …

Background Prolonged treatment with analgesic and sedative drugs in the pediatric
intensive care unit (PICU) may lead to undesirable effects such as dependence and …

Abstract Study Objective Withdrawal syndrome (WS) may be a critical drawback of opioid/
benzodiazepine weaning in children. The most effective intervention to reduce WS …

Background During treatment of acute respiratory failure (ARF) in children, sedation can
reduce pain, improve tolerance, and reduce the incidence of adverse events, so selecting an …

Introduction Dexmedetomidine (DEX) is frequently used as an adjunct agent for prolonged
sedation in the intensive care unit (ICU), though its effect on concomitant opioids or …

Abstract Keywords: children; dexmedetomidine; paediatrics; sedation EN children
dexmedetomidine paediatrics sedation 309 311 3 02/08/21 20210301 NES 210301 …